Wall Street analysts expect American Well Co. (NYSE:AMWL – Get Rating) to report sales of $62.30 million for the current fiscal quarter, Zacks Investment Research reports. Three analysts have provided estimates for American Well’s earnings. The highest sales estimate is $65.30 million and the lowest is $60.51 million. American Well reported sales of $60.22 million in the same quarter last year, which indicates a positive year-over-year growth rate of 3.5%. The firm is expected to report its next earnings results on Monday, January 1st.
On average, analysts expect that American Well will report full year sales of $273.83 million for the current fiscal year, with estimates ranging from $266.55 million to $278.90 million. For the next year, analysts anticipate that the firm will report sales of $308.49 million, with estimates ranging from $296.78 million to $322.26 million. Zacks’ sales calculations are an average based on a survey of sell-side research firms that cover American Well.
American Well (NYSE:AMWL – Get Rating) last posted its quarterly earnings data on Monday, May 9th. The company reported ($0.26) EPS for the quarter, missing analysts’ consensus estimates of ($0.22) by ($0.04). The business had revenue of $64.20 million during the quarter, compared to analyst estimates of $64.94 million. American Well had a negative return on equity of 16.72% and a negative net margin of 79.91%. American Well’s revenue for the quarter was up 11.5% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.16) EPS.
NYSE AMWL traded up $0.08 on Friday, reaching $3.18. The company had a trading volume of 41,505 shares, compared to its average volume of 2,995,806. The stock’s 50 day moving average is $3.55 and its 200-day moving average is $4.74. The stock has a market cap of $837.34 million, a price-to-earnings ratio of -3.92 and a beta of 0.86. American Well has a 52 week low of $2.52 and a 52 week high of $14.76.
In other American Well news, CEO Ido Schoenberg sold 40,720 shares of the firm’s stock in a transaction dated Monday, April 18th. The shares were sold at an average price of $3.58, for a total value of $145,777.60. Following the completion of the sale, the chief executive officer now directly owns 2,509,580 shares in the company, valued at $8,984,296.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CMO Mary Modahl sold 6,826 shares of the firm’s stock in a transaction that occurred on Tuesday, March 1st. The shares were sold at an average price of $3.94, for a total transaction of $26,894.44. The disclosure for this sale can be found here. In the last ninety days, insiders sold 321,047 shares of company stock worth $1,197,231. Insiders own 14.68% of the company’s stock.
Institutional investors have recently bought and sold shares of the company. Morgan Stanley grew its holdings in American Well by 198.1% during the 2nd quarter. Morgan Stanley now owns 2,318,691 shares of the company’s stock valued at $29,169,000 after purchasing an additional 1,540,792 shares during the last quarter. SG Americas Securities LLC purchased a new stake in American Well in the 3rd quarter valued at about $260,000. Raymond James Financial Services Advisors Inc. boosted its position in American Well by 31.1% in the 3rd quarter. Raymond James Financial Services Advisors Inc. now owns 16,052 shares of the company’s stock valued at $146,000 after buying an additional 3,805 shares during the period. Truist Financial Corp boosted its position in American Well by 36.5% in the 3rd quarter. Truist Financial Corp now owns 72,087 shares of the company’s stock valued at $657,000 after buying an additional 19,263 shares during the period. Finally, Swiss National Bank boosted its position in American Well by 1.5% in the 3rd quarter. Swiss National Bank now owns 115,300 shares of the company’s stock valued at $1,050,000 after buying an additional 1,700 shares during the period. Hedge funds and other institutional investors own 43.75% of the company’s stock.
About American Well (Get Rating)
American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care.
- Get a free copy of the StockNews.com research report on American Well (AMWL)
- Agilent Technologies Is Bottoming But Don’t Buy It Yet
- Institutions Ring The Register On Toll Brothers Stock
- Dick’s Sporting Goods Falls Flat On Weak Guidance
- Indie Semiconductor Stock is Putting in a Bottom
- It’s Time to Buy into Planet Fitness Stock
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for American Well Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Well and related companies with MarketBeat.com's FREE daily email newsletter.